Diabetes Pharmacology Flashcards

1
Q

Non-Pharm Treatment for Diabetes

A

goal group = Diabetes Self Management and Education & Support

Medical Nutrition Therapy (MNT)
- carb counting (used heavilty in T1DM)
- meal planning
- carbohydrate choices
- assessing protein and fat intake
- limit drinking alcohol
- sodium < 2300 mg/daily
- nonnutritive sweetener

education between carb counting and glucose spike

  • weight loss: 5% makes a big deal
  • physical activity
  • stop smoking

Psychosocila implications
sleep help!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

A1C goal for DM pts

A

most nonpregnant adults: target an A1c of < 7%

strict goals for less than 6.5%: need to ensure they can do this without significant hypoglycemia (think younger, healthy pt.)

less strict goals for less than 8%:
- those with history of severe hypoglycemia
- life expectancy limitied
- advanced vascular complications
- extensive comorbidities

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Medications to be used for…
- those with a + ASCVD
- thse with HIGH RISK for ASCVD

(what are the ascvd events and what meds should be used)

A

ASCVD means
- MI
- Stroke
- revascularization procedure
- TIA
- unstable angian
- amputation
- asymptomatic CAD

High Risk Individuals include
- those > 55 years old with 2+ of
- obesity
- hypertension
- smoking
- dyslipidemia
- albuminuria

GLP-1 receptor agonists: dulaglutide, liraglutide & semiglutide
AND/OR
SGLT2 inhibitors: empagliflozin, canagliflozin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Medications to be used for…
Heart Failure Patients
(HFpEF or HFrEF)

A

choose the SGLT2 inhibitors
- canagliflozin
- empagliflozin
- dapagliflozin
- ertugliflozin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Medications to be used for…
CKD pts (those with eGFR < 60 OR albuminuria)

A

SGLT2 inhibitors
- canagliflozin
- dapagliflozin
- empagliflozin

OR if the SGLT2 insnt an option or there is a CI

GLP-1’s can be used
- dulaglutide
- liraglutide
- semaglutide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Medications to be used for…
- specifically targeting glycemic lowering to get to target

what is always an option
what has “very high” lowering efficacy
“high”
“intermediate”

A

metformin can always be used
OR (in combo with each other or with metformin)

VERY HIGH (most successful)
- dulaglutide
- semaglutide
- tirzepatide (GLP, GIP combo)
- Insulin
- oral combo or injectable of a GLP and insulin together

HIGH
- the other GLP’s (liraglutide, exenatide, lixisenatide)
- metformin
- SGLT2i
- sulfonyureas
- TZDS

IMTERMEDIATE
- DPP-4 inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Medications for those who….
- need to target WEIGHT LOSS to manage their DM

A

those with High to Very High effiacy at managing weight loss

VERY HIGH
- semaglutide
- tirzepitide

HIGH
- dulaglutide
- liraglutide

INTERMED.
- exenatide
- lixisenatide
- SGLT2i

NO EFFECT ON WEIGHT
- metformin
- DPP-4i

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Basic Principles of Treatment for those with DM

A
  • always tackle lifestyle modifications first
  • initial treatment shold tackle DM and assocaited comorbidities

Pharmacotherapy should be started at the first visit and diagnosis unless there are contraindications

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Thearpy Choice depending on the A1C level

  • if A1C is > 1.5% above target
  • if A1C is > 10% OR BG > 300 or they have severe hyperglycemia
A

if A1C > 1.5% above target (so usually those with 8.5% or higher)
- start lifestyle changes
- start them on TWO MEDICATIONS: DUAL THERAPY INITIALLY

If A1C is > 10% or Blood Sugar > 300 or thye are severely hyperglycemic
- start lifestyle modifications
- start them on DUAL THERAPY: OF WHICH ONE IS BASAL INSULIN!!!
- example: metformin + basal insulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Metformin
(class)
MOA
onset of action

A

Metformin
(the only biguanide)

MOA
- decreases hepatic glucose production
- decreases intestinal absorbtion of glucose
- increasing peripheral glucose uptake and utilization (targets the resistance part)

Onset of Action
- takes days to 2 weeks
- excreted via urine

Benefits
- works really well
- no risk of hypoglycemia
- weight neutral
- cheap

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Metformin
Contraindications
Risks

A

Contraindicated in hypoperfusion states
- CI is GFR < 30: wont be cleared : risk of acidosis, hypoxia and dehydration

Risks
- watch metformin use with GFR 30-45: metformin wont cause renal dysfunction: but it wont get cleared as well through the kidneys and that can be an issue –> monitor kidney function well

Side Effects
- N/V
- diarrhea & bloating
- B12 deficiency
- lactic acidosis: if they already have bad kidneys this increases the risk

monitor the GFR annually!!

Iodine Contrast & Metformin
- temporarilty withhold metformin before contrast & reassess kidney function > 48 hours later
- because contrast impacts kidney function, hold metformin becuase if you dont lactic acidosis can occur

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Metformin
how is it given

A
  • titrate dose
  • strat with 500 with food
  • then change every 5-7 days
  • goal = 1000
  • switch to extended release formulation can decrease side effect profile
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Goals of DM Thearpy
Fasting plasma Glucose
Post-Prandial Glucose
A1C level

A

Fasting Plasma Glucose: 80-130
Post-Prandial Glucose: < 180 (2 hours after meal)
A1C: < 7%

reduce ASCVD risk and death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

GLP-1 Receptor Agonists
Names
MOA

A

can come as daily or weekly injections
- semaglutide is the only one now avalible as a pill

Names
- exenatide
- liraglutide
- lixisentaide
- dulaglutide
- semaglutide

MOA (works at insulin and glucagon)
- work to change the way in which the body responds to glucose dependent insulin secretion
- decreases the unnecessary release of glucagon (since glucagon is release becuase essentially no insulin is being released– triggered glucagon)
- slow gastric emptying : helps with weight loss

Benefits
- high & very high efficacy
- no risk of hypoglycemia (because its not increasing insulin secretion)
- weight loss
- ASCVD helpful and CKD helpful (some)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

GLP-1 receptor agonists
Risks & Side Effects

A

Risks
- black box warning: thyroid C-cell tumors (if history of this, avoid)

Side Effects
- nausea/vomiting/diarrhea
- pancreatitis + cholelithiasis/cholecystitis (if hx. of these; avoid these meds)
- injection site reaction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

GIP & GLP-1 combo med
Tirzepatide

MOA
benefits
side effects

A

Tirzepitide: a GLP and GIP combo med

MOA
- alters glucose dependent insulin secretion
- decreases the glucagon response
- slows gastric emptying

Benefits
- highly effective
- assocaited weight loss
- no risk of hypoglycemia

Side Effects
- BBW: thyroid C-cell tumors
- N/V/diarrhea
- pancreatitis and cholecyctitis/stones risk
- injection site reaction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

SGLT2 Inhibitors
Names
MOA

A

Names
- bexagliflozin
- canagliflozin
- dapagliflozin
- empagliflozin
- ertugliflozin

MOA
- reduce reabsorbtion of glucose in the lumen of kidney
- lowers teh renal threshold for emptying glucose
- overall increase excretion of glucose

Benefits
- intermed to high efficacy
- no risk of hypoglycemia
- weight loss (some)
- ASCVD, HF and CKD helpful

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

SGLT2 inhibitors

Risks & Side Effects

A

Risks
- UTI: fungal because sugary urine!
- volume depeletion & hypotension
- DKA (rare)
- fournier’s gangrene (rare)
- bone fractures risk: canagliflozin

RENAL ADJUSTMENTS
- need to consider renal adjustmenets with poor renal function & d/c once function is significantly decreased : since these meds work within the kidney

19
Q

DPP-4 Inhibitors
Names
MOA

A

Names: DPP4 = the Gliptins
- Alogliptin
- Linagliptin
- Saxagliptin
- Sitagliptin

MOA
- prolonged activity of the incretin hormones (stop their breakdown)
- therefore stops breakdown for GLP and GIP within the body so they have more of a chance to do their job

Benefits
- intermediate efficay
- no ris fo hypoglycemia
- weight neutral
- well tolerated

20
Q

DPP4 inhibitors

Risks & Side Effects

A

DONT USE GLP and DPP4’s TOGETHER: their MOA is too similar

Risks
- pancreatitis
- joint pain
- bullous pemphigoid
- avoid in HF: specifically saxigliptin

RENAL ADJUSTMENTS
- needed as kidney function declines in some pt.

21
Q

Thiazolidinnediones (TZDs)
Names
MOA

A

Names
- piglitazone
- rosiglitazone

MOA
- work at the PPAR gamma agonist: to improve the sensitivity to insulin at target cells

delayed onset of action: need to recheck blood sugar at 12 weeks to see if its working

Benefits
- works well
- no risk of hypoglycemia
- potential ASCVD decrease with piglitazone
- helpful in those with NASH: nonalcoholic steatohepatitis: inflammation + steatosis

22
Q

TZDs
Risks and Side Effects

A

Side Effects
BBW: heart failure
- increase fluid retention, edema dn therefore heart failure
- weight gain (edema + fat storage)
- bone fractures

Risks
- Bladder Cancer: piglitazone
- increased LDL with rosiglitazone : thats why its not helpful for ASCVD

23
Q

Sulfonyureas
Names
MOA

A

Names
- Glyburide
- Glipizide
- Glimepiride

MOA
- stimulate the insulin release from the beta cells
- reduce hepatic glucose output
- increase sensitivity to insulin

watch glyburide: has active metabolites: and in the urine they are excreted so if they have CKD or poor kidneys; this could be an issue

24
Q

Sulfonyureas
Risks & Side Effects

A

Risks
- hypoglcemia: since they’re just telling the beta cells to constantly pump out insulin!!!
- do not use glyburide in the elderly

Side Effects
- weight gain : adjustment like: if they stop eating as much this is less of an issue

increased CV mortality

25
Metglitindies Names MOA when are they used Side Effects
Names : Glitinides - nateglinide - repaglinide **MUST be taken WITH MEALS** MOA - stimulate insulin release from the beta cells: but in **response to glucose** - these are glucose dependnt medications!!!!! **DO NOT USE with sulfonyureas!!! too similar in their MOA as they both act on the beta cells** when are they used - taken with meals: there to help control post-prandial glucose spikes Side Effects - **hypoglycemia** - dizzy - URI
26
Alpha-Glucosidase Inhibitors Names MOA Place in Thearpy Side Effects
Names - Acarbose - Miglitol - **taken with meals: help to control post prandial glucose** MOA - inhibit the hydrolysis and ingestion of carbyhydrates, disaccharides and the absorbtion of glucose from the GI tract Place In thearpy - post-pradial gucose control Side Effects: think GI issues - flatulence - diarrhea - abd. pain
27
Amylin Mimetic Name MOA Place in Thearpy Avoid in ....
Name - Pramlintide MOA - taken before meals: there to help prolong gastric emptying & reduce the postpradial glucose spike: because less is being released over time - can help with satiety too since its delaying teh emptying of stomach & decrese caloric intake Place in thearpy - postprandial glucose control - taken with insulin: can reduce amount of bolus insulin needed by 50% Side Effects - **BBW: severe hypoglycemia when its taken with insulin** - headache - N/V - anorexia
28
Bolus Insulins
also called, coverage, pradial insulin RAPID ACTING - Aspart (Novolog) - Lispro (Humalog) - Glulisine (Apidra or Lyumjev) **all the above bolus insulins peak quickly, within approx. 15-30 minutes to cover the post meal spike and then are gone within hours** SHORT ACTING R (Regular insulin) = least like normal physiological insulin levels : in that it takes longer to peak and lasts longer in the system
29
Basal Insulin
insulin which covers for the whole day INTERMEDIATE ACTING N (NPH) - may need to dose 2x daily - **peaks** - risk of hypoglycemia - **can be mixed physically with bolus insulin** Detemir (Levemir) = often dosed 2x daily **has a flat peak** LONG ACTING Glargine (Lantus) = **peakless!!!** - no risk of hypoglycemia because its peakless Degludec (Tresibia)
30
Mixed Insulins intermediate and Short/Rapid Acting
70/30 - NPH (intermediate insulin) + regular insulin or protamine aspart (a shorter acting insulin) 75/25 50/50 first # = intermediate second # =short/rapid insulin
31
Inhaled Insulin what is it contraindications warnings
Inhaled Insulin (Afrezza) **a BOLUS insulin**: therefore you still need basal coverage Contraindicated in - COPD - asthma - other chronic lung diseases WARNINGs - lung cancer - pulmonary lung function - smokers
32
How to add or put someone with T2DM on insulin therapy
- if A1c is > 10% at dx. put them on dual therapy: insulin + other (metformin usually) - if you have tried other medications and they are still not to goal, add on insulin **Always start with adding basal insulin!!!** - start them on approx. 10 units a day or .1-.2 units per kg of body weight/per day - then increase/titrate up from there 2 units per 3 days until their fpg is at goal
33
what do you have to monitor for those pts. on insulin therapy levels & thresholds for glucose in hypoglycemia symptoms of
- weight gain - hypoglycemia Hypoglycemia Levels Level 1: glucose < 70 Level 2: glucose < 54 Levels 3: severe event - AMS/phsycailly altered - required assistance to treat Symptoms of hypoglycemia - tremor - sweating - tachycardic - dizzy - anxious - thristy - burry vision - weak/fatigue - HA - irritable/confused - syncope **alwasy check glucose level first before treating**
34
how do you treat hypoglycemia
For a Conscious Patient (glucose < 70) **15-15 rule** - give 15 grams of carbohydrates - wait 15 minutes - recheck sugar - keep repeating until glucose increased - then make sure they eat something (15 grams carbs = 3/4 glucose tablets, 1/4 cup juice, 1/2 can regular soda, 8oz milk) For Unconscious Patient - glucagon pen
35
Insulin Titration how is it done
**preferred way is patient to titrate themselves** - increase units every few days until FPG is within range - example: increase 2 units every 3 days until goal FPG Other Way = Provider Titrates - increased dose by 2-4 units every 1xor 2x weekly **if hypoglycemic: decrease the dose by 10-20%** then slowly up dose again
36
Co-Morbid conditions to be aware of in DM pt.
CVD: hypertension, dyslipidemia, CHD retinopathy neuropathy nephropathy
37
Health Maintence to consider in DM pts.
Immunizations - flu - pneumococcal - hepatitis - zoster - HPV - COVID dental visits Q6 months yearly albumin:creatitine ratio dilated eye exams neuropathy screening (monofilament testing) yearly
38
How to Adjust DM Thearpy - how often should treatment be reassessed - what do you consider
**reassess treatment every 3-6 months** consider... - fasting plasma glucose: should be between 80-130 - PPG: should be < 180 - amoutn of A1C lowering: should be around 7% watch: adding noninsulin therapy to metformin may not lower A1c as much as you want if the A1c is so high
39
What medications can be continued when adding insulin therapy to pts.
Metformin - keep on board: helps with weight (avoids gain) - adding this + insulin = good results Sulfonureas **take off** - controversial if you keep these on board - discontinue if you use bolus thearpy for sure TZDs **take off** - decrease dose or discontinue if you start insulin - **increased peripheral edema risk** good to keep on board - SGLT2 - DPP4 - GLP-1
40
How do you adjust Insulin in those already on it for DM control
**always adjust the insulin to change the glucose levels which are a result of whatver happened before example: midmorning spike: due to breakfast poor control** (also consider food intake too while adjusting insulin) Problem = fasting glucose - too high? increase basal insulin - too low? decreased basal Problem = 2 hours post breakfast - too high? increase bolus **with breakfast** - too low? decrease bolus same goes for lunch and dinner
41
Whats the deal with premixed Insulin - downsides - upsides - who is it good for
Downside - decreased flexibility in timing and variety of meals and activities - difficut to titrate dosing upsides - fewer injections Good For - those unwilling to inject multiple times a day - those unwilling to check glucose multiple times a day - those who have predicable/routine life & eat the same meals **always find appropriate dose first before switching**
42
How to swtich pt. from premixed to not premixed
- start at intermdeiatie dose and decrease by 20% - then titrate up from there
43
Adding Pradial Insulin
**if they are having post-prandial spikes and it just after one meal!!!** - can start with giving after largest meal or evenly split to every meal **start with 4 untis or 10% of their total daily dose of basal** then can titrate up 1-2 units or 10-15% twice weekly